title: What Can We Learn from Intraoperative Parathyroid Hormone Levels that Do Not Drop Appropriately?
abstract: BACKGROUND
  Parathyroidectomy remains the only definitive treatment for primary hyperparathyroidism. We studied our large series of parathyroidectomies to identify factors predictive of failure to meet intraoperative parathyroid hormone (IOPTH) monitoring criteria.
  
  
  METHODS
  We performed a retrospective cohort review of patients who underwent initial parathyroidectomy for primary hyperparathyroidism with IOPTH monitoring. Primary outcome was intraoperative failure, defined as failure to decrease IOPTH by ≥50 % and into normal range. Univariate and multivariate analyses were performed to determine factors associated with intraoperative failure. A subset analysis evaluated 6-month outcomes.
  
  
  RESULTS
  Of 2,185 subjects, 5.0 % (n = 110) experienced intraoperative failure. The intraoperative failure group had more multigland disease (35.2 vs. 16.6 %, p < 0.001) and smaller glands (1.3 vs. 1.5 cm, p = 0.048) compared to patients who experienced intraoperative success. On multivariate analysis, PTH level was statistically, but not clinically, significantly associated with intraoperative failure (odds ratio 1.0, 95 % confidence interval 1.000-1.003). Persistent hyperparathyroidism was identified in 2.5 % (n = 15) of 592 patients with ≥6 month follow-up. Median IOPTH decrease was lower in patients with persistent hyperparathyroidism (67.1 vs. 85.8 %, p < 0.001). IOPTH criteria were 93.7 % sensitive and 40.0 % specific for eucalcemia 6 months postoperatively. Of 15 patients with persistent hyperparathyroidism, 7 underwent reoperation with a 100 % cure rate. Reoperative diagnoses included ectopic mediastinal glands (n = 3), hyperplasia (n = 3), and missed second adenoma (n = 1).
  
  
  CONCLUSIONS
  Intraoperative failure is associated with higher rates of multigland disease and smaller parathyroid glands. Patients with persistent disease had significantly lower decreases in IOPTH, but half of patients who experienced failure by IOPTH criteria were eucalcemic 6 months postoperatively. All patients undergoing reoperation experienced successful cure.
authors.affiliation: Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA, heather.wachtel@uphs.upenn.edu.
authors.forename: Heather
authors.initials: H
authors.lastname: Wachtel
authors.forename: Isadora
authors.initials: I
authors.lastname: Cerullo
authors.forename: Edmund K
authors.initials: EK
authors.lastname: Bartlett
authors.forename: Rachel R
authors.initials: RR
authors.lastname: Kelz
authors.forename: Giorgos C
authors.initials: GC
authors.lastname: Karakousis
authors.forename: Douglas L
authors.initials: DL
authors.lastname: Fraker
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D049950:Hyperparathyroidism, Primary / Q000097:blood / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D016343:Monitoring, Intraoperative / Q000706:statistics & numerical data*; D010281:Parathyroid Hormone / Q000097:blood*; D016105:Parathyroidectomy; D011379:Prognosis; D012189:Retrospective Studies
chemical_list: D010281:Parathyroid Hormone